Jump to navigation
Disclose an Invention
Throughout March, we recognize Women’s History Month and the accomplishments and contributions of women throughout society. At Tech Launch Arizona, we’re taking this opportunity to celebrate the amazing women on our team.
As rats have been nibbling at the edges of society, UA researchers were developing a non-reproductive rodent model for studying menopause. That work yielded a humane, non-lethal rodent infertility formulation, now being commercialized by startup SenesTech.
In the lab of Louise Hecker, PhD, researchers have invented the first highly selective Nox4 small molecule inhibitors for the treatment of fibrotic disorders. The UA has licensed the technology to startup Fibronox to bring the invention to the public.
Funded by the National Eye Institute in the National Institutes of Health, the National Science Foundation, and Tech Launch Arizona, Jim Schwiegerling, PhD, professor at the University of Arizona College of Optical Sciences has developed a series of lenses that might shorten your trip to the eye doctor.
Jeffrey Pyun, PhD, professor in the Department of Chemistry and Biochemistry, has been elected as a Senior Member of the National Academy of Inventors. Dr. Pyun is one of just 66 inventors around the nation who earned the honor.
Six teams went head-to-head during a shark tank-style competition hosted by the College of Medicine – Tucson. For their work to reduce asthma attacks, Monica Kraft, MD, and Julie Ledford, PhD, were named the competition winners.
Last year, the drivers behind startup SinfoniaRx announced the launch of UAVenture Capital to support commercialization at the UA. Now, they are announcing a second fund targeting $100 million to further the advance of UA innovations.
Through TLA, the University of Arizona is partnering with Kerafast to license reagents that offer the opportunity for the development of a rapid, highly sensitive diagnostic test for Cryptosporidiosis, the leading cause of waterborne diseases among people in the U.S.
Researchers at the University of Arizona have discovered a protein that prevents mosquitoes from hatching, opening the possibility of developing new drugs that could act as birth control for mosquito populations.
Funded by NIH and the Packard Foundation, Michael Worobey and Tom Watts set out to push the limits of genome sequencing. Their findings have the potential of enhancing our ability to fight pandemics.